Patent Assignment
Reel/Frame 054660/0673
Corrective Assignment to Correct the Application Number Previously Recorded at Reel: 053135 Frame: 0049. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2020-12-09
Pages: 4
Assignor
NESTOR, JOHN J
Executed: 2018-01-26
Assignee
SPITFIRE PHARMA INC
400 OYSTER POINT BLVD, SUITE 202, SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Improved Peptide Pharmaceuticals for Treatment of Nash and Other Disorders
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 26, 2020
From: SPITFIRE PHARMA INC.
To: MEDERIS DIABETES LLC
Reel/Frame 053059/0865 →
Assignment of Assignor's Interest
Jul 7, 2020
From: NESTOR, JOHN
To: SPITFIRE PHARMA INC
Reel/Frame 053135/0049 →
Affidavit of Address Change
Feb 19, 2025
From: MEDERIS DIABETES, LLC
To: MEDERIS DIABETES LLC
Reel/Frame 070266/0875 →
Security Interest
May 14, 2025
From: ALTIMMUNE, INC.; SPITFIRE PHARMA, LLC
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 071108/0692 →